companydata.dkEvosep ApS: Financial statements 2024
CVR: 37510068
Evosep ApS (CVR 37510068) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 43,124,000 and a net result of DKK -2,613,000 compared with DKK 19,777,000 the year before. That is a decrease of 28.5% compared with the year before. Equity amounted to DKK 249,889,000. The solvency ratio was 94%. The company had 30 employees in the financial year.
- Gross Profit
- 43,124,000 kr.
- Profit/Loss
- -2,613,000 kr.
- Equity
- 249,889,000 kr.
- Total Assets
- 265,917,000 kr.
- Employees
- 30
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 43.1 mio. | -2.6 mio. | 249.9 mio. | 30 |
| 2023 | - | 60.4 mio. | 19.8 mio. | 252.7 mio. | 42 |
| 2022 | - | 53.5 mio. | -79.6 mio. | -34.4 mio. | 20 |
| 2021 | - | 36.9 mio. | 16.7 mio. | 45.2 mio. | 20 |
| 2020 | - | 21.6 mio. | 6.2 mio. | 28.5 mio. | 15 |
How creditworthy is Evosep ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of October 28, 2024, Daniel Mahony has joined the board of directors of Evosep ApS.
As of October 28, 2024, Stephen Neil van Helden has left the board of directors of Evosep ApS.
Evosep ApS has published its annual report for 2023. Gross profit came to DKK 60,355,000, and the net result was DKK 19,777,000.
About Evosep ApS
Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees. In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity amounted to DKK 154,548,000.